The insulin resistance-systemic vascular resistance-isolated diastolic hypertension axis: a metabolic framework for an overlooked hypertension phenotype - Report - MDSpire
Advertisement
The insulin resistance-systemic vascular resistance-isolated diastolic hypertension axis: a metabolic framework for an overlooked hypertension phenotype
Clinical Report: Insulin Resistance and Isolated Diastolic Hypertension
Overview
This report explores the relationship between insulin resistance (IR), systemic vascular resistance (SVR), and isolated diastolic hypertension (IDH). It highlights the significance of integrating metabolic and hemodynamic factors in understanding and managing IDH, particularly in young and middle-aged adults.
Background
Isolated diastolic hypertension (IDH) is increasingly recognized as a significant cardiovascular risk factor, especially in younger populations. Despite its prevalence, the optimal management and prognostic implications of IDH remain unclear, necessitating a deeper understanding of its underlying mechanisms. The proposed insulin resistance–systemic vascular resistance–IDH (IR–SVR–IDH) axis offers a novel framework for addressing this neglected hypertension phenotype.
Data Highlights
Revise to indicate the absence of specific data rather than stating 'no specific numerical data.'
Key Findings
IDH is characterized by elevated diastolic blood pressure with systolic blood pressure below hypertension thresholds.
Insulin resistance is linked to increased systemic vascular resistance, contributing to IDH.
Pragmatic surrogates for insulin resistance, such as HOMA-IR and TyG index, are associated with IDH risk.
Emerging data suggest that metabolic status influences cardiovascular risk in IDH patients.
Guideline definitions of IDH vary, impacting prevalence and management strategies.
Clinical Implications
Expand on how metabolic surrogates can be practically applied in clinical settings.
Conclusion
Integrating metabolic and hemodynamic assessments provides a more comprehensive understanding of IDH, supporting a precision-oriented approach to its management. Continued research is essential to clarify the prognostic significance and optimal treatment strategies for this hypertension phenotype.
